HHLR ADVISORS, LTD.
13F Holdings and Portfolio Analysis
Zhang Lei 2018 Q4 13F holdings, quarterly changes, portfolio value trend and position weight distribution.
HHLR ADVISORS, LTD. Overview
HHLR ADVISORS, LTD. held 32 stocks in 2018 Q4, with total market value around $2.41B.
HHLR ADVISORS, LTD.'s top five holdings in 2018 Q4: BeOne Medicines AG(ONC) 25.82%, JD.com, Inc.(JD) 13.06%, CHINA BIOLOGIC PRODS HLDGS I(CBPO) 8.66%, TAL Education Group(TAL) 8.27%, Alibaba Group Holding Limited(BABA) 8.03%.
- Portfolio Value
- $2.41B
- Current Holdings
- 32 stocks
- New / Increased
- 32 / 0
- Reduced / Exited
- 0 / 0
Current Holdings
| 1 | BeOne Medicines AGONC | 0.62 | 25.82% | 4.44 | $140.26 | $316.42 +125.60% | $140.26 | +4.44 | 0.25 | +$0.78B+125.60% | New |
| 2 | JD.com, Inc.JD | 0.31 | 13.06% | 15.04 | $20.93 | $33.07 +58.00% | $20.93 | +15.04 | 0.25 | +$0.18B+58.00% | New |
| 3 | CHINA BIOLOGIC PRODS HLDGS ICBPO | 0.21 | 8.66% | 2.75 | $75.91 | - | $75.91 | +2.75 | 0.25 | $0.00B0.00% | New |
| 4 | TAL Education GroupTAL | 0.20 | 8.27% | 7.48 | $26.68 | $11.09 -58.43% | $26.68 | +7.48 | 0.25 | -$0.12B-58.43% | New |
| 5 | Alibaba Group Holding LimitedBABA | 0.19 | 8.03% | 1.41 | $137.07 | $125.39 -8.52% | $137.07 | +1.41 | 0.25 | -$0.02B-8.52% | New |
| 6 | Mondelez International, Inc.MDLZ | 0.14 | 5.86% | 3.53 | $40.03 | $62.41 +55.91% | $40.03 | +3.53 | 0.25 | +$0.08B+55.91% | New |
| 7 | FibroGen, Inc.FGEN | 0.09 | 3.85% | 2.00 | $46.28 | $10.38 -77.57% | $46.28 | +2.00 | 0.25 | -$0.07B-77.57% | New |
| 8 | 58 COM INCWUBA | 0.08 | 3.34% | 1.48 | $54.21 | - | $54.21 | +1.48 | 0.25 | $0.00B0.00% | New |
| 9 | BLUEPRINT MEDICINES CORPBPMC | 0.08 | 3.20% | 1.43 | $53.91 | - | $53.91 | +1.43 | 0.25 | $0.00B0.00% | New |
| 10 | IKANG HEALTHCARE GROUP INC ADRKANG | 0.06 | 2.47% | 2.92 | $20.38 | - | $20.38 | +2.92 | 0.25 | $0.00B0.00% | New |
| 11 | MYOKARDIA INCMYOK | 0.04 | 1.74% | 0.86 | $48.86 | - | $48.86 | +0.86 | 0.25 | $0.00B0.00% | New |
| 12 | LINE CORPLN | 0.04 | 1.71% | 1.21 | $34.11 | $21.35 -37.41% | $34.11 | +1.21 | 0.25 | -$0.02B-37.41% | New |
| 13 | Kiniksa Pharmaceuticals International, plcKNSA | 0.04 | 1.62% | 1.39 | $28.09 | $38.64 +37.56% | $28.09 | +1.39 | 0.25 | +$0.01B+37.56% | New |
| 14 | PDD HOLDINGS INC COMMON STOCKPDD | 0.04 | 1.61% | 1.73 | $22.44 | $88.14 +292.81% | $22.44 | +1.73 | 0.25 | +$0.11B+292.81% | New |
| 15 | Snap Inc.SNAP | 0.04 | 1.58% | 6.93 | $5.51 | $7.65 +38.84% | $5.51 | +6.93 | 0.25 | +$0.01B+38.84% | New |
| 16 | BRIGHT SCHOLAR ED HLDGS LTDBEDU | 0.04 | 1.52% | 3.99 | $9.21 | - | $9.21 | +3.99 | 0.25 | $0.00B0.00% | New |
| 17 | Bilibili Inc.BILI | 0.03 | 1.32% | 2.18 | $14.59 | $27.05 +85.40% | $14.59 | +2.18 | 0.25 | +$0.03B+85.40% | New |
| 18 | Apellis Pharmaceuticals, Inc.APLS | 0.03 | 1.22% | 2.23 | $13.19 | $24.52 +85.90% | $13.19 | +2.23 | 0.25 | +$0.03B+85.90% | New |
| 19 | TENCENT MUSIC ENTMT GROUPTME | 0.02 | 0.81% | 1.47 | $13.22 | $9.22 -30.26% | $13.22 | +1.47 | 0.25 | -$0.01B-30.26% | New |
| 20 | LOXO ONCOLOGY INCLOXO | 0.02 | 0.76% | 0.13 | $140.07 | - | $140.07 | +0.13 | 0.25 | $0.00B0.00% | New |
| 21 | G1 THERAPEUTICS INCGTHX | 0.02 | 0.75% | 0.95 | $19.15 | - | $19.15 | +0.95 | 0.25 | $0.00B0.00% | New |
| 22 | iQIYI, Inc.IQ | 0.02 | 0.70% | 1.13 | $14.87 | $2.03 -86.35% | $14.87 | +1.13 | 0.25 | -$0.01B-86.35% | New |
| 23 | Sohu.com LimitedSOHU | 0.01 | 0.58% | 0.80 | $17.42 | $14.40 -17.33% | $17.42 | +0.80 | 0.25 | -$0.00B-17.33% | New |
| 24 | YY INCYY | 0.01 | 0.48% | 0.19 | $59.86 | - | $59.86 | +0.19 | 0.25 | $0.00B0.00% | New |
| 25 | Arvinas, Inc.ARVN | 0.01 | 0.33% | 0.63 | $12.85 | $9.52 -25.91% | $12.85 | +0.63 | 0.25 | -$0.00B-25.91% | New |
Showing 1-25 of 32
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis is an estimate and can differ materially from the actual cost, especially in edge cases.
Cost basis estimate: from the latest uninterrupted holding period, new or increased shares are added to the cost pool at the report price; reductions remove shares at the then-average cost. Example: buy 100 shares at $10 in Q1 and add 50 shares at $16 in Q2, estimated cost basis is (100 x 10 + 50 x 16) / 150 = $12 per share.
Return shows estimated dollar return on top and percentage return below. It uses current price when available, otherwise report price.
Portfolio Visuals
Track portfolio value, position weights and Top 10 history.